본문 바로가기

Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
피인용
Web of Science 25Scopus 28
FWCI (Scopus)
1.71
JCR IF
JCR 2022 8.2
ISSN
0141-8130

저자

  1. 신은국제1저자Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea
  2. 김병수Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea
  3. 강현구Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea
  4. 이학수Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea
  5. 박준형Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea
  6. Kang, JihoonEmory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
  7. Park, EunhoEbiogen Inc, Seoul, South Korea
  8. Jo, SunmiInje Univ, Sch Med, Haeundae Paik Hosp, Dept Radiat Oncol, Busan 48108, South Korea
  9. Kim, Hae YuInje Univ, Haeundae Paik Hosp, Coll Med, Dept Neurosurg, Busan 48108, South Korea
  10. 이정섭Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Biomed Res Inst,Dept Orthopaed Surg, Busan 49241, South Korea
  11. 이제명Pusan Natl Univ, Dept Naval Architecture & Ocean Engn, Busan 46241, South Korea
  12. Youn, HyesookSejong Univ, Dept Integrat Biosci & Biotechnol, Seoul 05006, South Korea
  13. 윤부현교신저자Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea

초록

Glioblastoma Multiforme (GBM) is a malignant primary brain tumor. Radiotherapy, one of the standard treatments for GBM patients, could induce GBM radioresistance via rewiring cellular metabolism. However, the precise mechanism attributing to GBM radioresistance or targeting strategies to overcome GBM radioresistance are lacking. Here, we demonstrate that SLC25A22, a mitochondrial bi-directional glutamate transporter, is upregulated and showed uni-directionality from mitochondria to cytosol in radioresistant GBM cells, resulting in accumulating cytosolic glutamate. However, mitochondrial glutaminolysis-mediated TCA cycle metabolites and OCR are maintained constantly. The accumulated cytosolic glutamate enhances the glutathione (GSH) production and proline synthesis in radioresistant GBM cells. Increased GSH protects cells against ionizing radiation (IR)-induced reactive oxygen species (ROS) whereas increased proline, a rate-limiting substrate for collagen biosynthesis, induces extracellular matrix (ECM) remodeling, leading to GBM invasive phenotypes. Finally, we discover that genetic inhibition of SLC25A22 using miR-184 mimic decreases GBM radioresistance and aggressiveness both in vitro and in vivo. Collectively, our study suggests that SLC25A22 upregulation confers GBM radioresistance by rewiring glutamate metabolism, and SLC25A22 could be a significant therapeutic target to overcome GBM radioresistance.

키워드

GlioblastomaRadioresistanceSLC25A22CANCER CELLSGLUTATHIONEEXPRESSIONPROLIFERATIONINHIBITIONMECHANISMSMUTATIONSBRAINGENE

식별자

Scopus EID
2-s2.0-85175737906
WoS UID
001110185500001